0001145549-23-016670.txt : 20230316 0001145549-23-016670.hdr.sgml : 20230316 20230316092432 ACCESSION NUMBER: 0001145549-23-016670 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230316 DATE AS OF CHANGE: 20230316 EFFECTIVENESS DATE: 20230316 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ADVISORS SERIES TRUST CENTRAL INDEX KEY: 0001027596 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-07959 FILM NUMBER: 23737403 BUSINESS ADDRESS: STREET 1: U.S BANCORP FUND SERVICES, LLC STREET 2: 615 E MICHIGAN STREET CITY: MILWAUKEE STATE: WI ZIP: 53202 BUSINESS PHONE: 414-765-5340 MAIL ADDRESS: STREET 1: 615 E MICHIGAN STREET STREET 2: MK-WI-LC2 CITY: MILWAUKEE STATE: WI ZIP: 53202 0001027596 S000005062 Capital Advisors Growth Fund C000013847 Investor Class CIAOX N-CEN 1 primary_doc.xml X0404 N-CEN LIVE 0001027596 XXXXXXXX false false false N-1A S000005062 true Advisors Series Trust 811-07959 0001027596 2549003Z0J6URS6I4Y63 615 East Michigan Street 3rd Floor Milwaukee 53202 US-WI US 18336121912 U.S. Bancorp Fund Services LLC 615 East Michigan Street 3rd Floor Milwaukee 53202 18336121912 Fund Administrator Transfer Agent and Fund Accountant records U.S. Bank National Association 1555 North RiverCenter Drive Suite 302 Milwaukee 53212 18336121912 Custody records Quasar Distributors LLC 111 East Kilbourn Avenue Suite 2200 Milwaukee 53202 18662516920 Distributor and Underwriter American Trust Investment Advisors LLC 67 Etna Road Suite 360 Lebanon 03766 6034486415 Investment Advisor ATAFX Capital Advisors Inc. 2222 South Utica Place Suite 300 Tulsa 74114 8662050523 Investment Advisor CIAOX Chase Investment Counsel Corporation 350 Old Ivy Way Suite 100 Charlottesville 22903 4342939104 Investment Advisor CHAIX Davidson Investment Advisors Inc. Davidson Building 8 Third Street North Great Falls 59401 4067276111 Investment Advisor DFMIX First Sentier Investors (US) LLC 10 East 53rd Street 21st Floor New York 10022 2124979980 Investment Advisor FLIIX FLIAX Fort Pitt Capital Group LLC 680 Andersen Drive Foster Plaza Ten Pittsburgh 15220 4129211822 Investment Advisor FPCGX Huber Capital Management LLC 1700 East Walnut Avenue Suite 460 El Segundo 90245 3102078400 Investment Advisor HULEX HUDEX HUSEX HUMEX Logan Capital Management, Inc. 3843 West Chester Pike Suite 150 Newtown Square 19073 2155691100 Investment Advisor LCLG O'Shaughnessy Asset Management LLC 6 Suburban Avenue Stamford 06901 2039753333 Investment Advisor OFVIX Pacific Income Advisers, Inc. 2321 Rosecrans Avenue Suite 1260 El Segundo 90245 3103931424 Investment Advisor PBBBX PMTGX PIASX PHYSX PIAMX Poplar Forest Capital LLC 225 South Lake Avenue Suite 950 Pasadena 91101 6263046000 Investment Advisor IPFPX IPFCX Pzena Investment Management LLC 320 Park Avenue 8th Floor New York 10022 2123551600 Investment Advisor PZIEX PZIMX PZISX PZIIX PZINX Scharf Investments LLC 16450 Los Gatos Boulevard Suite 207 Los Gatos 95032 8314296513 Investment Advisor LOGIX LOGOX WRLDX Semper Capital Management L.P. 52 Vanderbilt Avenue Suite 401 New York 10017 2126129050 Investment Advisor SEMMX SEMIX Shenkman Capital Management Inc. 151 West 42nd Street 29th Floor New York 10036 2128679090 Investment Advisor SFHIX SCFIX The Edgar Lomax Company 5971 Kingstowne Village Parkway Suite 240 Alexandria 22315 7037190026 Investment Advisor LOMAX VegTech LLC 1842 Purdue Ave Suite 103 Los Angeles 90025 14242378393 Investment Advisor EATV Distribution Cognizant, LLC 288 Pearl Street Suite 304 Monterey 93940 0000000000 Investment Advisor RVRB N N N N-1A 35 Y David G Mertens N/A N Joe D Redwine N/A N Raymond B Woolson N/A N Michael L Ceccato N/A 615 E Michigan St Milwaukee 53202 XXXXXX N N N N N N Quasar Distributors LLC 8-52323 000103848 N/A N N Tait Weller and Baker LLP 00445 N/A N N N N N N N Capital Advisors Growth Fund S000005062 254900B6RNVS0CT76410 N 1 0 0 N/A N N N N N/A N/A N/A Rule 12d1-1 (17 CFR 270.12d1-1) Rule 32a-4 (17 CFR 270.32a-4) Y Y N N Capital Advisors Inc 801-14050 000104643 254900B6RNVS0CT76410 N US Bancorp Fund Services LLC 85-11357 N1GZ7BBF3NP8GI976H15 N N N Intercontinental Exchange Inc 5493000F4ZO33MV32P92 N N US Bank National Association 6BYL5QZYBDK8S7L73M02 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N N U.S. Bancorp Fund Services LLC N1GZ7BBF3NP8GI976H15 N N N Charles Schwab & Company, Inc. 8-16514 000005393 549300ZP8XN77GK5BS04 306.900000000000 306.900000000000 Charles Schwab & Company, Inc. 8-16514 000005393 549300ZP8XN77GK5BS04 218977.000000000000 218977.000000000000 N 94279289.097000000000 N N N N true INTERNAL CONTROL RPT 2 capital123122ncen.htm

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING  

  

  

  

To the Board of Trustees of 

Advisors Series Trust and 

Shareholders of 

Capital Advisors Growth Fund 

  

  

In planning and performing our audit of the financial statements of Capital Advisors Growth Fund, a series of Advisors Series Trust, as of and for the year ended December 31, 2022, in accordance with the standards of the Public Company Accounting Oversight Board (United States), we considered the Fund’s internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund’s internal control over financial reporting. Accordingly, we express no such opinion. 

  

The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting.  In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a company’s assets that could have a material effect on the financial statements. 

  

Because of inherent limitations, internal control over financial reporting may not prevent or detect misstatements.  Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. 

  

A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis.  A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Fund’s annual or interim financial statements will not be prevented or detected on a timely basis. 

  

Our consideration of the Fund’s internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the Public Company Accounting Oversight Board (United States).  However, we noted no deficiencies in the Fund’s internal control over financial reporting and its operation, including controls over safeguarding securities that we consider to be material weaknesses as defined above as of December 31, 2022. 

  

This report is intended solely for the information and use of management, the Board of Trustees of the Advisors Series Trust and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties. 

  

/s/ TAIT, WELLER & BAKER LLP 

Philadelphia, Pennsylvania 

March 1, 2023